These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 21392952)
41. Multivariate analysis of factors predictive of brain metastases in localised non-small call lung carcinoma. Kilickap S; Aksoy S; Erman M Lung Cancer; 2005 Jul; 49(1):129; author reply 131. PubMed ID: 15949599 [No Abstract] [Full Text] [Related]
42. [Lung cancer in women: clinical features and factors related to survival]. Sen E; Kaya A; Erol S; Savas I; Gonullu U Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027 [TBL] [Abstract][Full Text] [Related]
43. Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival. Oxnard GR; Schwartz LH Cancer; 2010 Mar; 116(6):1615; author reply 1616. PubMed ID: 20108271 [No Abstract] [Full Text] [Related]
44. [Has survival of non-small-cell lung cancer patients been ameliorated over the course of the past 20 years?]. Milleron B Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S31-5. PubMed ID: 16273008 [No Abstract] [Full Text] [Related]
45. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635 [TBL] [Abstract][Full Text] [Related]
46. The role of prophylactic cranial radiation in the treatment of non-small-cell lung cancer. Laskin JJ; Sandler AB Clin Adv Hematol Oncol; 2003 Dec; 1(12):731-34. PubMed ID: 16258477 [TBL] [Abstract][Full Text] [Related]
47. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis. Kepka L; Cieslak E; Bujko K; Fijuth J; Wierzchowski M Acta Oncol; 2005; 44(4):389-98. PubMed ID: 16120548 [TBL] [Abstract][Full Text] [Related]
48. Influence of smoking status on treatment outcomes after post-operative radiation therapy for non-small-cell lung cancer. Nguyen SK; Masson-Côté L; Fortin A; Dagnault A Radiother Oncol; 2010 Jul; 96(1):89-93. PubMed ID: 20541274 [TBL] [Abstract][Full Text] [Related]
49. Impact of neoadjuvant radiation on survival in stage III non-small-cell lung cancer. Koshy M; Goloubeva O; Suntharalingam M Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1388-94. PubMed ID: 20605359 [TBL] [Abstract][Full Text] [Related]
50. [An analysis of the prognostic factors of stage I non-small cell lung cancer treated with radiation therapy]. Fuwa N; Morita K; Okumura E; Horikawa Y Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2218-24. PubMed ID: 2833547 [No Abstract] [Full Text] [Related]
52. Whole brain radiotherapy for patients with poor prognosis: possibilities for the impact of the QUARTZ trial. Jones JA; Simone CB Ann Palliat Med; 2015 Apr; 4(2):58-60. PubMed ID: 25971292 [No Abstract] [Full Text] [Related]
53. Does haemorrhage associated with brain metastases in lung cancer patients predict early mortality after cranial irradiation? Ampil F; Caldito G; Chittiboina P; Nanda A Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):646-7. PubMed ID: 22516857 [No Abstract] [Full Text] [Related]
54. Brain metastases from non-small-cell lung cancer: is there room for improvement? Franceschi E; Brandes AA Expert Rev Anticancer Ther; 2012 Apr; 12(4):421-3. PubMed ID: 22500678 [No Abstract] [Full Text] [Related]
55. Serum CA125 level predicts prognosis in patients with multiple brain metastases from non-small cell lung cancer before and after treatment of whole-brain radiotherapy. Zeng YC; Wu R; Wang SL; Chi F; Xing R; Cai WS; Fan GL; Fan YC; Zhong WZ; Wu LN; Chen XD; Chen HH; Xiao YP Med Oncol; 2014 Jul; 31(7):48. PubMed ID: 24913812 [TBL] [Abstract][Full Text] [Related]
56. The volume of brain metastases may be of prognostic significance in patients with non-small-cell lung cancer classified as RTOG-RPA classes 2 and 3. Plataniotis GA; Theofanopoulou M; Sotiriadou K; Vlychou M; Fountoulis G; Fezoulidis J Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):85-6. PubMed ID: 16477927 [No Abstract] [Full Text] [Related]
58. Society Bulletins. Oncol Res Treat; 2018; 41(5):342-344. PubMed ID: 29705793 [No Abstract] [Full Text] [Related]
59. What is the role of radiation therapy in locally advanced non-small-cell lung cancer? Livingston RB Ann Oncol; 1999 Mar; 10(3):259-60. PubMed ID: 10355567 [No Abstract] [Full Text] [Related]
60. MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer. Stella GM; Senetta R; Inghilleri S; Verdun di Cantogno L; Mantovani C; Piloni D; Scudeller L; Meloni F; Papotti M; Ricardi U; Cassoni P Neuro Oncol; 2016 Apr; 18(4):598-9. PubMed ID: 26905077 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]